NL-OMON34546已完成不适用
Targeted therapy selection based on tumor tissue kinase activity profiles for patients with advanced solid malignancies, an exploratory study - Therapy selection in advanced cancer patients based on kinase profiling
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 43
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Advanced solid malignancy, minimum age 18 years, no standard therapeutic options available, life expectancy of at least 12 weeks, measurable disease with at least one lesion assessable for biopsy.
排除标准
- •Cardiovascular conditions including congestive heartfailure NYHA class >2, recent myocardial infarction or uncontrolled coronary artery disease, uncontrolled hypertension; uncontrolled infections; anticancer treatment during study or within 4 weeks of start of study treatment.
研究者
相似试验
进行中（未招募）
不适用
Targeted therapy selection based on tumor tissue kinase activity profiles for patients with advanced solid malignancies, an exploratory studyEUCTR2010-019982-27-NLVU medical center45
招募中
不适用
Kinaseprofiling voor therapieselectie bij uitbehandelde kankerpatiënten.Gemetastaseerde solide tumorenVergevorderde (uitgezaaide of inoperabele) kankerAdvanced solid tumorsMetastasized or inoperable cancerNL-OMON22647Prof. dr. H.M.W. Verheul, M.D., Ph.D.Head Department of Medical OncologyVU University Medical CenterDe Boelelaan 11171081 HV AmsterdamThe NetherlandsTel: +31 (0)20-4444321/300Fax: + 31 (0)20-4444079Email: h.verheul@vumc.nl43
终止
不适用
Targeted Therapy Selection Based on Tumor Tissue Kinase Activity Profiles for Patients With Advanced Solid Malignancies, an Exploratory StudyAdvanced Solid TumorsInoperableMetastasisNCT01190241Amsterdam UMC, location VUmc45
招募中
不适用
Identification of therapeutic target and disease specific marker of atopic dermatitis using proteomic analysis for tissue and bloodDiseases of the skin and subcutaneous tissueKCT0000509Keimyung University31
招募中
不适用
Identfication of tumor-specific and tumor-associated antigens for potential clinical application in vaccination studies - Part: Squamous cell cancer of the head and neckC32C10Malignant neoplasm of larynxMalignant neoplasm of oropharynxDRKS00014018niversitätsklinikum Tübingen60